IMPORTANT EQUITY ALERT: Lundin Law PC Announces an Investigation of Neos Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 27, 2016 / Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Neos Therapeutics, Inc. (“Neos” or the “Company”) (Nasdaq: NEOS) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or by email at brian@lundinlawpc.com.

The investigation focuses on the Company’s August 11, 2016 announcement of its financial results for the second quarter of 2016, reporting that Neos missed its earnings expectations by $0.49 per share. When this news was announced, the Neos stock price fell.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 447840